Avalo Therapeutics Inc. (AVTX)
AVTX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$12.01
-9.29% on the day
Market cap
$644.1M
Small cap
Revenue · 2025
$59K
-86.6% on 2024
Net income · 2025
-$78.3M
-132642.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | AVTX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2015 |
| SEC CIK | 0001534120 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $59K |
| Net income | -$78.3M |
| Operating income | -$72.9M |
| Net margin | -132642.4% |
| Operating margin | -123601.7% |
| Revenue growth | -86.6% |
| Cash | $15.9M |
| Total assets | $116.5M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 10916.9× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-07-28 |
| Latest annual report | 10-K | 2026-03-23 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-08-06 |
| Latest proxy | DEFA14A | 2026-04-10 |
Source: SEC EDGAR submissions feed, 1,005 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -12.8% |
| 1 month | -26.3% |
| 3 months | -33.8% |
| Year to date | -34.8% |
| 1 year | -13.4% |
| From 52-week high | -48.2% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ABUS | Arbutus Biopharma Corporation | $4.11 | -0.96% | $630.0M |
| PHAR | Pharming Group N.V. ADS each representing 10 | $9.44 | -1.77% | $666.7M |
| WVE | Wave Life Sciences Inc. | $3.14 | -4.27% | $618.7M |
| ZVRA | Zevra Therapeutics Inc. | $10.39 | -8.22% | $617.0M |
| VSTM | Verastem Inc. | $7.45 | -9.70% | $674.7M |
| OLMA | Olema Pharmaceuticals Inc. | $7.02 | -4.62% | $614.2M |
| DSGN | Design Therapeutics Inc. | $9.78 | -10.36% | $612.0M |
| IVA | Inventiva S.A. American Depository Shares | $2.87 | -8.01% | $678.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier